Senyo Health App - Connecting Primary Care to Substance Use Disorder Treatment Using a Telehealth Collaborative Care Platform
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- Mayo Clinic
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Brief Substance Craving Scale (BSCS)
研究概览
简要总结
The purpose of this study is to examine the barriers, facilitators, and optimal processes for implementing a digitally enhanced screening, brief intervention, and referral to treatment (SBIRT) model for Substance Use Disorder SUD treatment among Mayo primary care clinics.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ability to read, write, and understand English
- •Minimum DAST (1+), audit-C score (3+)
- •Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care.
- •Access to or willingness to obtain a Primary care provider at a participating Mayo Clinic site;
- •Eligibility determined by ASAM Assessment
排除标准
- •Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis
- •Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment
- •Needing a higher level of mental health care as demonstrated by ASAM32 assessment.
- •Decline to answer suicidality questions.
- •Already admitted into or about to initiate treatment in another addiction treatment program.
- •Currently attending High School.
研究组 & 干预措施
Senyo
Subjects to the Senyo group will begin receiving intervention immediately, and will move to the follow-up phase after 12 weeks.
干预措施: Senyo App (Behavioral)
Senyo
Subjects to the Senyo group will begin receiving intervention immediately, and will move to the follow-up phase after 12 weeks.
干预措施: Follow-up (Behavioral)
结局指标
主要结局
Brief Substance Craving Scale (BSCS)
时间窗: Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months
The Brief Substance Craving Scale is a 16 item, self-report instrument that assesses craving for substances of abuse over a 24 hour period. Intensity and frequency of craving are recorded on a five-point Likert scale, with 0 = Not at all, 1 = Slight, 2 = Moderate, 3 = Considerable, and 4 = Extreme.
Timeline Follow Back
时间窗: Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months
Timeline Follow Back is an assessment to document substance use over a specific period of time
Brief Substance Craving Scale (BSCS)
时间窗: Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months
The Brief Substance Craving Scale is a 16 item, self-report instrument that assesses craving for substances of abuse over a 24 hour period. Intensity and frequency of craving are recorded on a five-point Likert scale, with 0 = Not at all, 1 = Slight, 2 = Moderate, 3 = Considerable, and 4 = Extreme.
次要结局
- Generalized Anxiety Disorder-7 (GAD-7)(Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months)
- Patient Health Questionnaire-9 (PHQ-9)(Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months)
研究者
Tyler S. Oesterle
Principal Investigator
Mayo Clinic